Floatz logo

Fludarabine

Large B-Cell Lymphoma

M.D. Anderson Cancer CenterSmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
73/ 100

Competitive context

70 Active assets in the Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Axicabtagene Ciloleucel
Zhejiang Cancer Hospital
Phase 4BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 4BB
Etoposide
University of California, Davis
Phase 2/3BB
Adriamycin
Ruijin Hospital
Phase 3BB
Prednisone
Ruijin Hospital
Phase 3BB

View all 49 →

Same molecule, other indications

Fludarabine is also rated in:

adult T-cell leukemia/lymphomaActive
BBB
Indicative · Phase 2
76 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative · Phase 2
76 / 100
View asset →
Fanconi anemiaActive
BBB
Indicative · Phase 2/3
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →